{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:43:53Z","timestamp":1783572233584,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent studies have reported numerous predictors for adverse outcomes in COVID-19 disease. However, there have been few simple clinical risk scores available for prompt risk stratification. The objective is to develop a simple risk score for predicting severe COVID-19 disease using territory-wide data based on simple clinical and laboratory variables. Consecutive patients admitted to Hong Kong\u2019s public hospitals between 1 January and 22 August 2020 and diagnosed with COVID-19, as confirmed by RT-PCR, were included. The primary outcome was composite intensive care unit admission, need for intubation or death with follow-up until 8 September 2020. An external independent cohort from Wuhan was used for model validation. COVID-19 testing was performed in 237,493 patients and 4442 patients (median age 44.8 years old, 95% confidence interval (CI): [28.9, 60.8]); 50% males) were tested positive. Of these, 209 patients (4.8%) met the primary outcome. A risk score including the following components was derived from Cox regression: gender, age, diabetes mellitus, hypertension, atrial fibrillation, heart failure, ischemic heart disease, peripheral vascular disease, stroke, dementia, liver diseases, gastrointestinal bleeding, cancer, increases in neutrophil count, potassium, urea, creatinine, aspartate transaminase, alanine transaminase, bilirubin, D-dimer, high sensitive troponin-I, lactate dehydrogenase, activated partial thromboplastin time, prothrombin time, and C-reactive protein, as well as decreases in lymphocyte count, platelet, hematocrit, albumin, sodium, low-density lipoprotein, high-density lipoprotein, cholesterol, glucose, and base excess. The model based on test results taken on the day of admission demonstrated an excellent predictive value. Incorporation of test results on successive time points did not further improve risk prediction. The derived score system was evaluated with out-of-sample five-cross-validation (AUC: 0.86, 95% CI: 0.82\u20130.91) and external validation (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009202, AUC: 0.89, 95% CI: 0.85\u20130.93). A simple clinical score accurately predicted severe COVID-19 disease, even without including symptoms, blood pressure or oxygen status on presentation, or chest radiograph results.\n                  <\/jats:p>","DOI":"10.1038\/s41746-021-00433-4","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T06:13:19Z","timestamp":1617862399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3780-9033","authenticated-orcid":false,"given":"Jiandong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Ka Kei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Dajun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-763X","authenticated-orcid":false,"given":"Keith Sai Kit","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Ka Chung","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Man Yung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5510-1253","authenticated-orcid":false,"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"433_CR1","doi-asserted-by":"publisher","unstructured":"Mody, A. et al. The clinical course of COVID-19 disease in a US hospital system: a multi-state analysis. Am. J. Epidemiol. https:\/\/doi.org\/10.1093\/aje\/kwaa286 (2020).","DOI":"10.1093\/aje\/kwaa286"},{"key":"433_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243710","volume":"15","author":"RJ Thomson","year":"2020","unstructured":"Thomson, R. J. et al. Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: a prospective observational cohort study. PLoS ONE 15, e0243710 (2020).","journal-title":"PLoS ONE"},{"key":"433_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MCC.0000000000000793","volume":"27","author":"G Grasselli","year":"2021","unstructured":"Grasselli, G., Cattaneo, E. & Scaravilli, V. Ventilation of coronavirus disease 2019 patients. Curr. Opin. Crit. Care 27, 6\u201312 (2021).","journal-title":"Curr. Opin. Crit. Care"},{"key":"433_CR4","doi-asserted-by":"publisher","unstructured":"Coromilas, E. J. et al. Worldwide survey of COVID-19 associated arrhythmias. Circ. Arrhythm. Electrophysiol. https:\/\/doi.org\/10.1161\/CIRCEP.120.009458 (2021).","DOI":"10.1161\/CIRCEP.120.009458"},{"key":"433_CR5","doi-asserted-by":"publisher","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017 (2020).","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"433_CR6","doi-asserted-by":"publisher","unstructured":"Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.0950 (2020).","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"433_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11883-020-00842-y","volume":"22","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Roever, L., Tse, G. & Liu, T. 2019-novel coronavirus-related acute cardiac injury cannot be ignored. Curr. Atheroscler. Rep. 22, 14 (2020).","journal-title":"Curr. Atheroscler. Rep."},{"key":"433_CR8","doi-asserted-by":"publisher","unstructured":"Li, X. et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart https:\/\/doi.org\/10.1136\/heartjnl-2020-317062 (2020).","DOI":"10.1136\/heartjnl-2020-317062"},{"key":"433_CR9","doi-asserted-by":"publisher","unstructured":"Tan, E., Song, J., Deane, A. M. & Plummer, M. P. Global impact of coronavirus disease 2019 infection requiring admission to the ICU: a systematic review and meta-analysis. Chest https:\/\/doi.org\/10.1016\/j.chest.2020.10.014 (2020).","DOI":"10.1016\/j.chest.2020.10.014"},{"key":"433_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/joa3.12405","volume":"36","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Cardiac arrhythmias in patients with COVID-19. J. Arrhythm. 36, 827\u2013836 (2020).","journal-title":"J. Arrhythm."},{"key":"433_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243602","volume":"15","author":"Y Hui","year":"2020","unstructured":"Hui, Y. et al. The risk factors for mortality of diabetic patients with severe COVID-19: a retrospective study of 167 severe COVID-19 cases in Wuhan. PLoS ONE 15, e0243602 (2020).","journal-title":"PLoS ONE"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11883-020-00880-6","volume":"22","author":"R Baral","year":"2020","unstructured":"Baral, R., White, M. & Vassiliou, V. S. Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients. Curr. Atheroscler. Rep. 22, 61 (2020).","journal-title":"Curr. Atheroscler. Rep."},{"key":"433_CR13","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2020-323668 (2020).","DOI":"10.1136\/gutjnl-2020-323668"},{"key":"433_CR14","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.jacc.2020.07.068","volume":"76","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Tse, G., Li, G., Lip, G. Y. H. & Liu, T. ACE inhibitors and angiotensin II receptor blockers may have different impact on prognosis of COVID-19. J. Am. Coll. Cardiol. 76, 2041 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"433_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00466-z","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J. Intensive Care 8, 49 (2020).","journal-title":"J. Intensive Care"},{"key":"433_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"433_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai, Q. et al. COVID-19: abnormal liver function tests. J. Hepatol. 73, 566\u2013574 (2020).","journal-title":"J. Hepatol."},{"key":"433_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"433_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40121-020-00349-8","volume":"9","author":"JI Forrest","year":"2020","unstructured":"Forrest, J. I., Rayner, C. R., Park, J. J. H. & Mills, E. J. Early treatment of COVID-19 disease: a missed opportunity. Infect. Dis. Ther. 9, 715\u2013720 (2020).","journal-title":"Infect. Dis. Ther."},{"key":"433_CR20","doi-asserted-by":"publisher","first-page":"107666","DOI":"10.1016\/j.jdiacomp.2020.107666","volume":"34","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Wei, Y., Chen, M., Wan, Q. & Chen, X. Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. J. Diabetes Complications 34, 107666 (2020).","journal-title":"J. Diabetes Complications"},{"key":"433_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14740\/jocmr4201","volume":"12","author":"S Bose","year":"2020","unstructured":"Bose, S. et al. Medical management of COVID-19: evidence and experience. J. Clin. Med. Res. 12, 329\u2013343 (2020).","journal-title":"J. Clin. Med. Res."},{"key":"433_CR22","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","volume":"35","author":"M Million","year":"2020","unstructured":"Million, M. et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France. Travel Med. Infect. Dis. 35, 101738 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"433_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejim.2020.04.019","volume":"77","author":"G de Simone","year":"2020","unstructured":"de Simone, G. & Mancusi, C. COVID-19: timing is important. Eur. J. Intern. Med. 77, 134\u2013135 (2020).","journal-title":"Eur. J. Intern. Med."},{"key":"433_CR24","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","volume":"180","author":"W Liang","year":"2020","unstructured":"Liang, W. et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern. Med. 180, 1081\u20131089 (2020).","journal-title":"JAMA Intern. Med."},{"key":"433_CR25","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ 370, m3339 (2020).","journal-title":"BMJ"},{"key":"433_CR26","doi-asserted-by":"publisher","first-page":"m1328","DOI":"10.1136\/bmj.m1328","volume":"369","author":"L Wynants","year":"2020","unstructured":"Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ 369, m1328 (2020).","journal-title":"BMJ"},{"key":"433_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243262","volume":"15","author":"D Bertsimas","year":"2020","unstructured":"Bertsimas, D. et al. COVID-19 mortality risk assessment: an international multi-center study. PLoS ONE 15, e0243262 (2020).","journal-title":"PLoS ONE"},{"key":"433_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-020-2284-y","volume":"582","author":"JS Jia","year":"2020","unstructured":"Jia, J. S. et al. Population flow drives spatio-temporal distribution of COVID-19 in China. Nature 582, 389\u2013394 (2020).","journal-title":"Nature"},{"key":"433_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00683-6","volume":"9","author":"H Wan","year":"2020","unstructured":"Wan, H., Cui, J.-A. & Yang, G.-J. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province. Infect. Dis. Poverty 9, 116 (2020).","journal-title":"Infect. Dis. Poverty"},{"key":"433_CR30","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Identifying main and interaction effects of risk factors to predict intensive care admission in patients hospitalized with COVID-19: a retrospective cohort study in Hong Kong. Preprint at medRxiv. https:\/\/doi.org\/10.1101\/2020.06.30.20143651 (2020).","DOI":"10.1101\/2020.06.30.20143651"},{"key":"433_CR31","doi-asserted-by":"publisher","first-page":"556886","DOI":"10.3389\/fmed.2020.556886","volume":"7","author":"G Cao","year":"2020","unstructured":"Cao, G. et al. A risk prediction model for evaluating the disease progression of covid-19 pneumonia. Front. Med. (Lausanne) 7, 556886 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"433_CR32","doi-asserted-by":"publisher","first-page":"042314","DOI":"10.1103\/PhysRevE.102.042314","volume":"102","author":"Y Ye","year":"2020","unstructured":"Ye, Y. et al. Effect of heterogeneous risk perception on information diffusion, behavior change, and disease transmission. Phys. Rev. E 102, 042314 (2020).","journal-title":"Phys. Rev. E"},{"key":"433_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18297-9","volume":"11","author":"N Barda","year":"2020","unstructured":"Barda, N. et al. Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nat. Commun. 11, 4439 (2020).","journal-title":"Nat. Commun."},{"key":"433_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2020.03.004","volume":"301","author":"CK Li","year":"2020","unstructured":"Li, C. K. et al. Association of NPAC score with survival after acute myocardial infarction. Atherosclerosis 301, 30\u201336 (2020).","journal-title":"Atherosclerosis"},{"key":"433_CR35","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1093\/rheumatology\/kez576","volume":"59","author":"C Ju","year":"2020","unstructured":"Ju, C. et al. Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users. Rheumatology 59, 2340\u20132349 (2020).","journal-title":"Rheumatology"},{"key":"433_CR36","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Anticoagulant or antiplatelet use and severe COVID-19 disease: a propensity score-matched territory-wide study. Pharmacol. Res. https:\/\/doi.org\/10.1016\/j.phrs.2021.105473 (2021).","DOI":"10.1016\/j.phrs.2021.105473"},{"key":"433_CR37","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or anti-viral therapies in COVID-19: a population-based study. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.26904 (2021). Epub ahead of print.","DOI":"10.1002\/jmv.26904"},{"key":"433_CR38","volume":"25","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Electrocardiograhic characteristics in patients with coronavirus infection: a single-center observational study. Ann. Noninvasive Electrocardiol. 25, e12805 (2020).","journal-title":"Ann. Noninvasive Electrocardiol."}],"updated-by":[{"DOI":"10.1038\/s41746-022-00586-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000}}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00433-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00433-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:48:49Z","timestamp":1670075329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-021-00433-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1038\/s41746-021-00433-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.21.20217380","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41746-022-00586-w","URL":"https:\/\/doi.org\/10.1038\/s41746-022-00586-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}